<GlossaryTerm id="CDR0000796827"><TermName>triple-positive breast cancer</TermName><TermPronunciation>(TRIH-pul-PAH-zih-tiv brest KAN-ser)</TermPronunciation><TermDefinition><DefinitionText>A type of
          breast cancer in which the tumor cells have estrogen
          receptors, progesterone receptors, and a larger than normal
          number of HER2 receptors on their surface. Knowing if
          breast cancer is triple positive may help plan the best
          treatment, which may include hormone therapy and drugs that
          target the HER2 receptor.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000797985" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;triple-positive breast cancer&quot;" language="en" id="_2"/><MediaLink ref="CDR0000798905" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;cáncer de mama triple positivo&quot;" language="es" id="_6"/><SpanishTermName>cáncer de mama triple positivo</SpanishTermName><SpanishTermDefinition><DefinitionText>Tipo de cáncer de mama cuyas células
tumorales tienen
en su superficie
receptores de estrógeno, receptores de
progesterona y cantidades mayores que las normales de
receptores
HER2.
Saber si un cáncer de mama es triple positivo tal vez sirva para
planificar el
tratamiento más apropiado, que
a veces incluye
terapia con hormonas y medicamentos que se dirigen al
receptor HER2.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2019-04-10</DateFirstPublished><DateLastModified>2020-09-23</DateLastModified></GlossaryTerm>
